EP3110442
Breytt mengishnettlu fHbp fjölpeptíð
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
27.2.2015EP published:
14.10.2020EP application number:
15707351.1
EP translation filed:
10.12.2020Grant published:
15.1.2021EPO information:
European Patent Register
Max expiry date:
26.2.2035Expiry date:
26.2.2027Next due date:
28.2.2027
Title:
MODIFIED MENINGOCOCCAL FHBP POLYPEPTIDES
Timeline
Today
27.2.2015EP application
14.10.2020EP Publication
10.12.2020Translation submitted
15.1.2021Registration published
26.2.2027Expires
Owner
Name:
GlaxoSmithKline Biologicals SAAddress:
Rue de l'Institut 89, 1330 Rixensart, BE
Inventor
Name:
BOTTOMLEY, MatthewAddress:
53100 Siena, IT
Name:
MALITO, EnricoAddress:
53100 Siena, IT
Name:
MARTINELLI, ManueleAddress:
53100 Siena, IT
Name:
SCARSELLI, MariaAddress:
53100 Siena, IT
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
14157399Date:
28.2.2014Country:
EP
Number:
14177566Date:
17.7.2014Country:
EP
Classification
Categories:
A61K 39/095, C07K 14/22, C07K 14/095
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 13.1.2021
Expires: 26.2.2022
Payer: Örn Þór slf.
Number: 8
Paid: 19.1.2022
Expires: 26.2.2023
Payer: Patice ehf.
Number: 9
Paid: 19.1.2023
Expires: 26.2.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 29.1.2024
Expires: 26.2.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 29.1.2025
Expires: 26.2.2026
Payer: Árnason Faktor ehf.
Number: 12
Paid: 16.2.2026
Expires: 26.2.2027
Payer: Árnason Faktor ehf.